Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M. Talha Ugurlu"'
Autor:
Mohammad O. Hoque, Anju Singh, Edward Gabrielson, Charles M. Rudin, Giuseppe Bogina, Enrico Munari, Evgeny Izumchenko, M. Talha Ugurlu, Pritam Sadhukhan, Yoshikuni Inokawa, Akira Ooki, Masahiro Shibata
This is a file of "Supplementary Data".
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c2abb5d549bb5ffd555be69215adad8
https://doi.org/10.1158/1535-7163.22519258
https://doi.org/10.1158/1535-7163.22519258
Publikováno v:
Cancers
Cancers, Vol 13, Iss 5098, p 5098 (2021)
Cancers, Vol 13, Iss 5098, p 5098 (2021)
Simple Summary Effective cancer treatment hinges upon overcoming therapeutic resistance mechanisms that allow for the continued proliferation of cancer cell subpopulations. Exposure to pharmacotherapy invariably leads to resistance as tumor cells wit
Autor:
Monika K. Prelowska, Dawid Mehlich, M. Talha Ugurlu, Hanna Kedzierska, Aleksandra Cwiek, Artur Kosnik, Klaudia Kaminska, Anna A. Marusiak, Dominika Nowis
Publikováno v:
Cancer Letters. 526:363
Autor:
Hanna Kędzierska, Artur Kosnik, M. Talha Ugurlu, Dominika Nowis, Dawid Mehlich, Anna A. Marusiak, Klaudia Kaminska, Aleksandra Cwiek, Monika K. Prelowska
Publikováno v:
Cancer letters. 507
Proteasome inhibitors (PIs), used in the treatment of plasma cell myeloma (PCM), interfere with the degradation of misfolded proteins leading to activation of unfolded protein response (UPR) and cell death. However, despite initial strong antimyeloma
Autor:
Edward Gabrielson, M. Talha Ugurlu, Mohammad O. Hoque, Yoshikuni Inokawa, Pritam Sadhukhan, Charles M. Rudin, Giuseppe Bogina, Masahiro Shibata, Evgeny Izumchenko, Enrico Munari, Anju Singh, Akira Ooki
Publikováno v:
Mol Cancer Ther
Cancer stem cells (CSC) are highly resistant to conventional chemotherapeutic drugs. YAP1 and STAT3 are the two transcription factors that facilitate the therapeutic resistance and expansion of CSCs. The objective of this study was to understand the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbbdb18201634a15a1e432e7bc2a1453
http://hdl.handle.net/11379/554631
http://hdl.handle.net/11379/554631
Autor:
Pritam Sadhukhan, Mingxiao Feng, Emily Illingworth, Ido Sloma, M. Talha Ugurlu, Fenna Sille, Woonyoung Choi, David J. McConkey, Mohammad Hoque
Publikováno v:
Molecular Cancer Therapeutics. 20:P174-P174
YAP1 is a principal component of the Hippo pathway and is considered as one of the critical regulators of tumorigenesis. Recent studies indicate that YAP1 can suppress the antitumor immunity and influence the differentiation of regulatory T cells (Tr
Publikováno v:
Molecular Cancer Therapeutics. 20:P094-P094
Urothelial Carcinoma of Bladder (UCB) is a disease of multiple origins of the same bladder with varying in morphology and genetic changes. The origin of spatially different tumors in the same bladder has been proposed to occur through clonal changes
Publikováno v:
Cancer Research. 80:PO-016
Chemoresistance and poor immune sensitivity are one of the major challenges to treat different cancer types including lung, bladder and head & neck. Different epigenetic regulators and cancer stem cells (CSCs) regulatory pathways play a critical role
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.